Literature DB >> 6113924

Prednisolone metabolism and excretion in the isolated perfused rat kidney.

M L Rocci, S J Szefler, M Acara, W J Jusko.   

Abstract

The isolated perfused rat kidney was used to identify factors responsible for the renal elimination of prednisolone (Pn). Pn was recirculated at initial concentrations varying from 100 to 1000 ng/ml for 90 min. Perfusate and urine samples were assayed for Pn and prednisone by HPLC. Protein binding of Pn was measured by using 3H-Pn and equilibrium dialysis at 37 degrees C. There were no significant differences in perfusate flow, glomerular filtration rate, urine flow, or sodium excretion between control and steroid experiments. Partial metabolism of Pn to prednisone occurred in all studies. The total kidney clearance (CIT) of Pn ranged from 0.39 to 1.24 ml/min/100 g of rat body weight with approximately half of the Pn dose unaccountable for as either Pn or prednisone. The apparent percentage of the Pn dose excreted unchanged in the urine ranged from 1.9 to 6.4% and was not related to Pn dose. The apparent urinary clearances of Pn and its metabolite, prednisone, normalized for inulin clearance (fractional excretion) were variable with means of 0.068 and 0.095, respectively. The fractional excretions of Pn and prednisone were related to the fraction of filtered water excreted but not to perfusate concentration. Thus, the extent of urinary clearance of these corticosteroids is related to glomerular filtration and passive tubular reabsorption. The perfused rat kidney reflects the urinary and renal metabolic clearance of Pn without the complication of dose-dependent disposition.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6113924

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  10 in total

1.  Physiologically Based Pharmacokinetic Modeling Involving Nonlinear Plasma and Tissue Binding: Application to Prednisolone and Prednisone in Rats.

Authors:  Xiaonan Li; Debra C DuBois; Richard R Almon; William J Jusko
Journal:  J Pharmacol Exp Ther       Date:  2020-09-03       Impact factor: 4.030

2.  Modeling Corticosteroid Pharmacokinetics and Pharmacodynamics, Part II: Sex Differences in Methylprednisolone Pharmacokinetics and Corticosterone Suppression.

Authors:  Vivaswath S Ayyar; Debra C DuBois; Toshimichi Nakamura; Richard R Almon; William J Jusko
Journal:  J Pharmacol Exp Ther       Date:  2019-06-13       Impact factor: 4.030

Review 3.  Transitioning from Basic toward Systems Pharmacodynamic Models: Lessons from Corticosteroids.

Authors:  Vivaswath S Ayyar; William J Jusko
Journal:  Pharmacol Rev       Date:  2020-04       Impact factor: 25.468

Review 4.  Clinical pharmacokinetics and pharmacodynamics of prednisolone and prednisone in solid organ transplantation.

Authors:  Troels K Bergmann; Katherine A Barraclough; Katie J Lee; Christine E Staatz
Journal:  Clin Pharmacokinet       Date:  2012-11       Impact factor: 6.447

5.  Absorption of prednisolone in patients with Crohn's disease.

Authors:  J A Shaffer; S E Williams; L A Turnberg; J B Houston; M Rowland
Journal:  Gut       Date:  1983-03       Impact factor: 23.059

6.  Dose-dependent pharmacokinetics of prednisolone in normal and adrenalectomized rats.

Authors:  F D Boudinot; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1986-10

7.  Simulation of monoclonal antibody pharmacokinetics in humans using a minimal physiologically based model.

Authors:  Linzhong Li; Iain Gardner; Miroslav Dostalek; Masoud Jamei
Journal:  AAPS J       Date:  2014-07-09       Impact factor: 4.009

8.  The determination of essential clearance, volume, and residence time parameters of recirculating metabolic systems: the reversible metabolism of methylprednisolone and methylprednisone in rabbits.

Authors:  W F Ebling; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1986-12

9.  Applications of minimal physiologically-based pharmacokinetic models.

Authors:  Yanguang Cao; William J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2012-11-23       Impact factor: 2.745

10.  The availability of drug by liposomal drug delivery : Individual kinetics and tissue distribution of encapsulated and released drug in mice after administration of PEGylated liposomal prednisolone phosphate.

Authors:  Evelien A W Smits; José A Soetekouw; Ebel H E Pieters; Coen J P Smits; Nicolette de Wijs-Rot; Herman Vromans
Journal:  Invest New Drugs       Date:  2018-12-13       Impact factor: 3.850

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.